GlassScriptPhysician profile
Carl W Ogletree
NPI 1194778258
$5,984.45
in general payments reported to CMS, 2019-2025
34 companies · $1,105 in 2025
The $1,105 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $958 · 2020: $404 · 2021: $77.74 · 2022: $866 · 2023: $1,364 · 2024: $1,211 · 2025: $1,105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,646 · Education: $33.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,645.62 |
| Education | $33.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $601.31 | 2023-2025 | Gemtesa, Orgovyx |
| Coloplast Corp | $468.95 | 2019-2025 | Titan |
| Pfizer INC. | $430.01 | 2019-2025 | |
| Procept Biorobotics Corporation | $417.11 | 2023-2024 | Aquabeam Robotic System, Aquabeam System |
| Janssen Biotech, INC. | $354.39 | 2019-2025 | Erleada, Akeega |
| Boston Scientific Corporation | $339.50 | 2019-2025 | Spaceoar Vue System - 10ml |
| Neotract INC. | $324.64 | 2019-2020 | |
| Antares Pharma, INC. | $289.87 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Endo Pharmaceuticals INC. | $278.54 | 2019-2023 | Xiaflex, Aveed |
| Teleflex LLC | $266.02 | 2023-2025 | Urolift, Barrigel |
| Abbvie INC. | $253.20 | 2019-2025 | |
| Ferring Pharmaceuticals INC. | $237.02 | 2019-2025 | Adstiladrin |
| Urovant Sciences INC | $223.14 | 2022 | |
| Caldera Medical, INC | $210.83 | 2019-2023 | Desara |
| Astellas Pharma US INC | $209.87 | 2019-2025 | Xtandi, Padcev |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verity Pharmaceuticals INC. | $194.00 | 2022-2024 | Trelstar, Tlando |
| Endo USA, INC. | $179.93 | 2024-2025 | Aveed, Xiaflex |
| Bayer Healthcare Pharmaceuticals INC. | $121.61 | 2022-2025 | |
| Dendreon Pharmaceuticals LLC | $87.01 | 2024-2025 | Provenge |
| Halozyme INC | $86.79 | 2023 | |
| Azurity Pharmaceuticals, INC. | $59.77 | 2025 | Azmiro |
| Myovant Sciences INC. | $44.18 | 2022 | |
| Mission Pharmacal Company | $43.05 | 2019-2022 | |
| Tolmar, INC. | $40.14 | 2023-2025 | Jatenzo |
| Axonics, INC. | $35.20 | 2024 | Axonics |
| Immunitybio, INC. | $34.67 | 2025 | |
| Avadel Specialty Pharmaceuticals, LLC | $26.44 | 2019 | |
| Calyxo, INC. | $23.61 | 2023 | Cvac Aspiration System |
| Amgen INC. | $23.49 | 2019 | |
| Accord Healthcare, INC. | $19.27 | 2023 | |
| Ambu INC. | $18.97 | 2021 | |
| Travere Therapeutics, INC. | $15.65 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $13.22 | 2023 | Seglentis |
| Tolmar Pharmaceuticals, INC. | $13.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carl Ogletree listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.